Portfolio company
illumicell
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Illumicell AI develops a portable cellular imaging platform for rapid, point-of-care semen analysis serving fertility clinics, urologists and pharmaceutical companies.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
PATH FERTILITY
This company develops epigenetic sperm quality tests for men and clinicians to identify subfertility missed by standard semen analysis.
FertereX
This company develops a photobiomodulation therapy device designed to improve sperm quality and testosterone levels for men experiencing fertility issues.
Fellow Health
The company develops mail-in semen analysis and fertility testing kits for men, urology practices and reproductive health clinics.
EarlySight
EarlySight develops a cellular-level retinal imaging camera and AI software for eye doctors to detect and monitor ophthalmic diseases at microscopic scales.
CytoSwim
CytoSwim manufactures sperm selection devices for fertility clinics to isolate high-quality cells for use in assisted reproductive treatments like IVF.
Lightcast Discovery
Lightcast Discovery develops a microfluidic platform using light to manipulate droplets for single-cell functional analysis for pharmaceutical companies and academic research institutions.
AI Optics
This company develops handheld retinal imaging devices and artificial intelligence software for healthcare providers to screen and diagnose eye diseases at the point of care.
Lightcast
Lightcast develops a microfluidic platform for single-cell functional analysis to support drug discovery and translational research for pharmaceutical companies and academic institutions.
